Evidence in Focus: REDAPT™ Stem is a Viable Option for Femoral Revision Surgery | Smith & Nephew

Author: Smith & Nephew

After a median 12-month follow up, there were no cases of dislocation or periprosthetic fracture in patients with Paprosky type II to IV femoral defects

23 April 2018